Prenatal ultrasound screening company BrightHeart raised a $12.8 million Series A co-led by Odyssée Venture and GO Capital, CEO Cécile Dupont tells Axios exclusively.
Why it matters: Congenital heart defects (CHD) are underdiagnosed and affect roughly 1 in 100 newborns.
